Infectious Diseases in Critical Care Medicine

intrinsically resistant VRE component. This results in increased resistant group D enterococci, i.e., VRE in hospitals. However, ...

METHICILLIN-SENSITIVE STAPHYLOCOCCUS AUREUS (MSSA) & METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) Clinically Relevant ...

and clinical presentation. In addition to PVL toxin, PVL-positive HA-MRSA strains also produce other toxins that are virulence f ...

Clinical Spectrum of MSSA/MRSA Infection MSSA/MRSA skin/soft tissue infections.As mentioned previously, staphylococcal infection ...

temporary/semipermanent catheters. Alternately, in patients with prosthetic devices, i.e., artificial joints, heart valves, plas ...

influenza pneumonia may be due to MSSA, CO/CA-MRSA. The virulence of MSSA/MRSA CAP is the same if the MRSA strain is CA-MRSA (PV ...

therapy (1,10,26). While bactericidal drugs are preferable in the treatment of MRSA ABE, linezolid and minocycline have been cli ...

resistance. There has been no clinically important resistance that has developed to any of the anti-MRSA drugs except vancomycin ...

wall thickening/permeability-mediated resistance increases, resulting in the loss of vanco- mycin usefulness (1,68,69). As menti ...

Assaduab O, Askarian M, Stadler M, et al. Prevalence of vancomycin-resistant enterococci colonization and risk factors in chron ...

Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003–2004 influenza ...

Ruhe JJ, Menon A. Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections c ...

28 Antibiotic Therapy of Multidrug-Resistant Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumannii in Criti ...

chloramphenicol, polymyxin B, colistin, and tigeglycine. High-resistance potential antibiotics used for GNBs include imipenem, c ...

resistant” isolates. When using antibiotics with a wide “toxic/therapeutic ratio,” i.e., beta- lactams, many “relatively resista ...

important but not most frequent cause of NP/HAP/VAP isP. aeruginosa, there is a tendency to “cover” isolates cultured from respi ...

Patients with MDRP. aeruginosaurosepsis following urological instrumentation/procedures may be effectively treated with colistin ...

tigecycline is a drug, with few, if any side effects, the dose may be increased without adverse effects if administered in suffi ...

can be achieved most simply by avoiding the unnecessary treatment of colonized respiratory secretions or urine (6,7,10). Other i ...

not be treated/covered and is difficult to eradicate. Because colonization is difficult to eradicate, antibiotic therapy of colo ...